SSTI Earnings

SSTI reported its earnings on 2026-03-03, showcasing a revenue of 24.79M against an estimate of 24.63M, resulting in a 0.65% surprise. The EPS was -0.22, surpassing the expected -0.2 by -10%. The stock experienced a -18.9% price change on the earnings day and a -11.24% change over the next five days, reflecting market reactions to the results.

Following SSTI's earnings announcement on 2026-03-03, the stock price moved by -18.9% on the day of the release. Over the subsequent five days, it saw a -11.24% change. Historically, SSTI's stock price tends to shift by an average of 1.06% in the 10 days leading up to earnings and 1.16% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SSTI's annual revenue to reach 27.31M, while the EPS is projected at -0.11. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SSTI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SSTI's stock price typically moves by 1.06% in the 10 days before its earnings and 1.16% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.11 and revenue of 27.31M.

The earnings call reveals multiple concerns: lowered revenue and EBITDA guidance for 2025, increased net loss, and nonrenewal of a major contract. Despite some positive developments, such as the CrimeTracer Gen3 launch and SafePointe momentum, the Q&A highlighted uncertainties in international deployments and cost-saving measures, with management providing unclear responses. The negative sentiment is further reinforced by reduced revenue retention and the failure to meet EBITDA guidance. These factors suggest a likely negative stock price reaction over the next two weeks.